Angels Investments in High Tech

1 stories about Angels Investments in High Tech
מריוס נכט 2

Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax

17.07.19|Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1